trial

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)

NCTId NCT00453804
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 15
Sponsored by State University of New York - Upstate Medical University
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
15
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2006-07
Primary completion
—
Eligibility
ALL · 18 Years · 69 Years

Interventions & indications

Drugs
injectable naltrexoneoral naltrexone

Sponsors

State University of New York - Upstate Medical UniversityLead Sponsor
CephalonCollaborator

Investigators

1
Steven L Batki, MDPrincipal Investigator

Sites

1 total
Syracuse, United States

Facts & assertions

3 sourced
Enrollment
15
Phase
PHASE4
Status
COMPLETED
relationships
The graph out of here
drug
injectable naltrexone
drug
oral naltrexone
drug
lead_sponsor
State University of New York - Upstate Medical University
company
collaborator
Cephalon
company
indication
Bipolar Disorder
indication
Bipolar Disorders
indication
Alcohol Dependence
indication
investigator
Steven L Batki, MD
person